Canada’s Drug Agency (CDA-AMC)
In December 2023, it was announced that Canada’s Drug Agency would be built from CADTH. The work of the drug agency expands on CADTH’s existing mandate and functions — which spans drugs, medical devices, and clinical interventions — and includes new work streams such as:
- improving the appropriate prescribing and use of medications
- increasing pan-Canadian data collection and expanding access to drug and treatment data, including real-world evidence data
- reducing drug system duplication and lack of coordination
CADTH adopted the new name Canada’s Drug Agency (CDA-AMC) as of May 1, 2024. An official launch will occur later this year.
Winner of the 2023 PIP Grant Competition
Participants and supporters of the 2023 PIP are pleased to announce that Dr. Nawal Amhis is the winner of the 2023 PIP grant competition, a one-year grant of $15,000, for her project, “Remodeling of the pancreatic tumour microenvironment with oncolytic virotherapy.” Dr. Amhis is a medical res... Read More »
Participants and supporters of the 2023 PIP are pleased to announce that Dr. Nawal Amhis is the winner of the 2023 PIP grant competition, a one-year grant of $15,000, for her project, “Remodeling of the pancreatic tumour microenvironment with oncolytic virotherapy.” Dr. Amhis is a medical res... Read More »